Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study

OBJECTIVE: Clozapine is the treatment of choice for refractory schizophrenia. The aim of this study was to compare the pharmacokinetics of the brand name (Clozaril) formulation and a generic formulation (Clzapine) of clozapine in Korean schizophrenic patients. METHODS: A prospective, randomized, cro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Psychiatry Investig
Hlavní autoři: Woo, Young Sup, Wang, Hee-Ryung, Yoon, Bo-Hyun, Lee, Sang-Yeol, Lee, Kwang Hun, Seo, Jeong Seok, Bahk, Won-Myong
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Neuropsychiatric Association 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504918/
https://ncbi.nlm.nih.gov/pubmed/26207129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2015.12.3.356
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky